Cornerstone Planning Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Buy
155
+7
+5% +$466 ﹤0.01% 864
2026
Q1
$8.8K Buy
148
+11
+8% +$766 ﹤0.01% 929
2025
Q4
$10.1K Buy
137
+69
+101% +$4.46K ﹤0.01% 801
2025
Q3
$6.19K Sell
68
-93
-58% -$7.36K ﹤0.01% 894
2025
Q2
$12.1K Sell
161
-6
-4% -$470 ﹤0.01% 516
2025
Q1
$11.2K Buy
167
+27
+19% +$2.2K ﹤0.01% 539
2024
Q4
$12.3K Sell
140
-4
-3% -$296 ﹤0.01% 389
2024
Q3
$10.4K Sell
144
-66
-31% -$5.42K ﹤0.01% 407
2024
Q2
$15.2K Sell
210
-12
-5% -$1.52K ﹤0.01% 362
2024
Q1
$28.5K Buy
222
+123
+124% +$15.5K 0.01% 250
2023
Q4
$12.3K Sell
99
-28
-22% -$2.86K ﹤0.01% 393
2023
Q3
$11.8K Sell
127
-3
-2% -$338 ﹤0.01% 392
2023
Q2
$16.7K Buy
+130
New +$15.7K 0.01% 472
2022
Q4
$13.8K Buy
+130
New +$14.3K 0.01% 544

Other funds holding DXCM

Cornerstone Planning Group's DXCM Position: Q2 2026 in Review

Cornerstone Planning Group increased its DexCom (DXCM) stake by 4.7% in Q2 2026, buying an estimated $466 and bringing the position to 155 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #864.

Cornerstone Planning Group first reported a position in DXCM in Q4 2022 and has held it in 14 quarters since. The position peaked at $28.5K in Q1 2024. 540 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Cornerstone Planning Group held 155 shares of DexCom worth $11.1K as of Q2 2026.
  • Cornerstone Planning Group bought 7 DexCom shares in Q2 2026, an estimated $466.
  • DexCom made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #864 holding.
  • Cornerstone Planning Group first reported a position in DexCom in Q4 2022 and has held it in 14 quarters since.
  • Cornerstone Planning Group's DexCom position peaked at $28.5K in Q1 2024.
  • 540 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.